AB015. Current diagnostic approaches in ILD: ILD vs . non-specialty clinics

Background The approach to diagnosing interstitial lung diseases (ILDs) has evolved. While high resolution computed tomography (HRCT) and multidisciplinary discussion are key components in the diagnostic process, the approval of pirfenidone and nintedanib for idiopathic pulmonary fibrosis (IPF) has spurred greater urgency to improve the diagnostic process. In this study, we evaluated responses from pulmonologist in ILD and non-specialty clinics to assess the current ILD diagnostic evaluation and impact of a novel genomic classifier under development.